Compounded tirzepatide from Apothecary Pharma recalled over possible contamination
Published
The company is recalling 22 lots of its 18 mg/mL multi-dose vials, with beyond-use dates from Oct. 7 to Nov. 26, 2026. Brand-name Mounjaro and Zepbound aren't affected. The FDA had earlier cited the company for sterility problems. If you have these vials, check the lot number and call your prescriber or pharmacy.
Source: The Boston Globe
This is a plain-language summary. Read the original source for full details.